Subscribe: NCCAM Featured Content
Added By: Feedage Forager Feedage Grade B rated
Language: English
career development  fda  flawless beauty  food drug  health  kratom  nccih  products  research  small business  training career 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: NCCAM Featured Content

NCCIH Featured Content


PDX Aromatics Recalls Kratom Powder Because Of Possible Health Risk

Mon, 12 Mar 2018 12:05:27 -0400

Kratom-containing powder products recalled.

How Do New NIH Human Subjects Policies Impact Training and Career Development Awards?

Tue, 06 Mar 2018 13:16:13 -0500

In this blog post, Dr. Lanay Mudd describes NIH initiatives designed to enhance the accountability and transparency of clinical research.

Spring Research Lectures on Pain and Its Management

Mon, 05 Mar 2018 16:07:38 -0500

Information about three upcoming lectures on pain and pain managementby NCCIH-funded researchers on pain and its management (forming NCCIH’s Spring 2018 Integrative Medicine Research Lecture Series).

NCCIH Resources for Research Training and Career Development

Fri, 02 Mar 2018 13:54:09 -0500

In this blog post, NCCIH Training Officer Dr. Lanay Mudd discusses research training and career development opportunities.

Study Identifies Two Substances Derived From Plants That May Have the Potential To Treat Depression

Wed, 28 Feb 2018 13:08:59 -0500


Researchers look at plant-derived natural products for new antidepressants.

Complementary Health Approaches for Hypertension

Fri, 23 Feb 2018 13:56:57 -0500


Find out more about complementary health practices and hypertension (high blood pressure).

FDA Investigates Multistate Outbreak of Salmonella Infections Linked to Products Reported to Contain Kratom

Fri, 23 Feb 2018 09:51:40 -0500

The FDA is advising consumers to avoid kratom and kratom-containing products due to a multistate outbreak of salmonellosis.

NCCIH's SBIR/STTR Programs: Funding Small Business Research and Development

Fri, 23 Feb 2018 11:35:29 -0500

In this blog post Dr. Merav Sabri discusses funding opportunities for small businesses – the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse

Mon, 12 Feb 2018 12:42:18 -0500

Over the past several months, there have been many questions raised about the botanical substance known as kratom. Our concerns related to this product, and the actions we’ve taken, are rooted in sound science and are in the interest of protecting public health. However, we recognize that there is still much that is unknown about kratom, which is why we’ve taken some significant steps to advance the scientific understanding of this product and how it works in the body.

Bulletproof 360, Inc. Issues Allergy Alert on Undeclared Milk in Collagen Protein Dietary Supplement

Fri, 26 Jan 2018 11:23:25 -0500

Out of an abundance of caution, Bulletproof 360, Inc. is voluntarily recalling one lot #1017088 of Bulletproof Collagen Protein dietary supplement due to undeclared milk.  People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product.

Job Opportunity: NCCIH Scientific Review Officer

Fri, 02 Feb 2018 14:06:24 -0500

In this blog post, Dr. Martina Schmidt addresses the merits of joining NCCIH/NIH as a health scientist administrator/scientific review officer.

Flawless Beauty, LLC Issues Voluntary Recall of Unapproved Drugs

Fri, 26 Jan 2018 11:21:35 -0500

In accordance with a Consent Decree of Permanent Injunction ordered in the United States District Court for the District of New Jersey, Flawless Beauty, LLC is voluntarily recalling all lots of nineteen different products sold individually or as part of multi-unit kits alleged by the U.S. Food and Drug Administration (“FDA”) to be misbranded or unapproved new drugs pursuant to the Federal Food, Drug, and Cosmetic Act. The FDA believes that these drugs present serious public health risks. To date, Flawless Beauty has not received any reports of adverse events related to this recall.

FTC, FDA Warn Companies about Marketing and Selling Opioid Cessation Products

Fri, 26 Jan 2018 11:20:54 -0500

The Federal Trade Commission and the U.S. Food and Drug Administration (FDA) today posted warning letters to 11 marketers and distributors of opioid cessation products for illegally marketing products with unproven claims about their ability to help in the treatment of opioid addiction and withdrawal.

Break Ventures/California Basics Recalls "Zero For Him" 150ct Lot#1710-638 Because of Possible Health Risk

Wed, 24 Jan 2018 12:39:04 -0500

Break Ventures/California Basics recalls product “Zero for Him 150ct” due to potential Salmonella contamination.

Updates on NCCIH Clinical Trials Among Talks To Be Streamed at Feb. 9 Advisory Council Meeting

Fri, 19 Jan 2018 18:56:59 -0500

On Friday, February 9, the National Advisory Council for Complementary and Integrative Health (NACCIH) will hold its second meeting of Fiscal Year 2018. NCCIH grantees, potential applicants, and others may find it useful to hear updates on the Center’s activities, policies, and funding priorities. We will provide a livestream of the meeting’s open session via NIH Videocast from 10:00 a.m. to 3:05 p.m. ET.

Investigating the Safety of the Probiotic Lactobacillus reuteri in Infants With Colic

Wed, 24 Jan 2018 09:56:13 -0500


Recent research, funded in part by NCCIH, suggests that the probiotic strain Lactobacillus reuteri DSM 17938 may be safe for use in infants with colic.